Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RFA-MBN for Vertebral Compression Fractures
NCT03651804Phase 4Withdrawn
- Sponsor
- University of California, Davis
- Start
- Apr 2019
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by University of California, Davis. Primary endpoint: Visual Analog Scale at 6 months. Planned start Apr 2019; status: withdrawn.
Beyond the preview
Go deeper on NCT03651804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651804.